NysnoBio Kicks Off Manufacturing
NysnoBio has started manufacturing their first product at Thermo Fisher Scientific's giant new plant in the Boston metro area. This is Thermo Fisher's fifth viral vector manufacturing facility—not only their biggest, but one of the largest in the world.
Jennifer Johnston, PhD, founder and CEO of NysnoBio, toured the plant in September with other biotech executives, journalists, and other visitors.
Says Dr. Johnston:
“Generating high quality AAV products for delivery into humans has been one of the biggest challenges in gene therapy products. NysnoBio was in Boston to kick off our NB001 product manufacturing at the amazing new Thermo Fisher Scientific (TFS) AAV manufacturing facility in Plainville, MA, along with other established companies, whose approved gene therapy products demonstrate the high quality of the CDMO work at TFS. We're on the way to joining our pioneering colleagues in creating approved products that improve patient lives with our fantastic CDMO partner!”
Read the full article here.
Contact NysnoBio to get involved or learn more:
info@nysnobio.com
